{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/incontinence-urinary-in-women/diagnosis/assessing-for-underlying-causes-contributing-factors/","result":{"pageContext":{"chapter":{"id":"9897aa86-8c09-5550-8496-da8cb12787bf","slug":"assessing-for-underlying-causes-contributing-factors","fullItemName":"Assessing for underlying causes and contributing factors","depth":2,"htmlHeader":"<!-- begin field 71842f53-98a5-41c4-8d2a-7d506e468365 --><h2>Identifying underlying causes and contributing factors</h2><!-- end field 71842f53-98a5-41c4-8d2a-7d506e468365 -->","summary":"","htmlStringContent":"<!-- begin item 02db10d0-56b9-4e76-9f3b-434771d013a3 --><!-- begin field 0a467ff8-eb89-4f51-9106-b1e35270d8d8 --><ul><li><strong>Consider and look for the presence of any <a class=\"topic-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/background-information/causes-contributing-factors/\">causes</a> or conditions that may exacerbate urinary incontinence or overactive bladder.</strong><ul><li><strong>Ask about fluid intake and the amount and type of fluids, for example, caffeine and alcohol.</strong></li><li><strong>Identify symptoms indicating an increased likelihood of a more serious diagnosis, </strong>for example, haematuria, persisting bladder or urethral pain, recurrent urinary tract infection, constant leakage (suggests a fistula). </li><li><strong>Ask about any drugs </strong>the woman is taking that could be causing or exacerbating the incontinence.<ul><li>Drugs that may be associated with urinary incontinence include alpha-1 adrenoceptor antagonists, antipsychotics, anticholinergics, anti-parkinsonism drugs, antidepressants, benzodiazepines, beta-adrenoceptor antagonists, diuretics, and hormone replacement therapy.</li></ul></li><li><strong>Ask about previous history of </strong>investigations and treatment, urinary tract disorders, low spinal surgery, prolapse or hysterectomy, and obstetric and gynaecological history.</li><li><strong>Consider and look for neurological conditions, </strong>for example, multiple sclerosis, spinal cord injury, Parkinson's disease.<strong> </strong></li><li><strong>Consider and look for systemic disease, </strong>such as heart failure and diabetes mellitus. </li><li><strong>Consider and look for cognitive impairment. </strong></li></ul></li><li><strong>Perform urine dipstick analysis in all women presenting with urinary incontinence to test for blood, glucose, protein, leucocytes, and nitrites.</strong><ul><li>If the woman has symptoms of a urinary tract infection (UTI) and dipstick analysis is positive for both leukocytes and nitrites, send a mid-stream urine (MSU) sample for culture and sensitivities and prescribe an antibiotic whilst waiting for the culture result.<ul><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-women/\">Urinary tract infection (lower) - women</a>.</li></ul></li></ul></li></ul><!-- end field 0a467ff8-eb89-4f51-9106-b1e35270d8d8 --><!-- end item 02db10d0-56b9-4e76-9f3b-434771d013a3 -->","topic":{"id":"c16535c5-1fa2-5d4a-a89f-9863872fca0e","topicId":"9e411d60-4060-4d95-8511-0998688cea47","topicName":"Incontinence - urinary, in women","slug":"incontinence-urinary-in-women","lastRevised":"Last revised in October 2019","chapters":[{"id":"592d340e-2c89-5e8e-9781-8398ef51af2c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"93b3be44-57e0-59a2-b936-4b447f0b2961","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c15069c4-b8dd-5092-9861-e20a636b9367","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3dc5fefe-1cf0-54d7-92d3-e1c0c60c6fb9","slug":"changes","fullItemName":"Changes"},{"id":"fb9741e6-b4f0-5ec2-ada2-a14af327feed","slug":"update","fullItemName":"Update"}]},{"id":"1ae974b5-487a-5fdf-88b5-6d9ed1e83525","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"399a4681-e92c-5e84-a738-fded957e135f","slug":"goals","fullItemName":"Goals"},{"id":"6507910a-37cb-51a9-8d3d-b69725293a87","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9cd9dcb7-4d7b-5d3b-aa75-6fb40bf5928b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f79e3765-8adb-5e3f-b68f-48aa4ddeb34b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e1ab1bca-96c7-5187-894e-1e1fe32f92d6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"97c63b91-f53e-5694-b807-0899dd34d53a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0c2e43fc-1afb-59f4-8819-0ff5edc09eeb","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3ab1ad04-1d9d-52bc-b4c9-ad0787598df3","slug":"definition","fullItemName":"Definition"},{"id":"a9c53f9f-2962-5eb2-8cae-91fc90a5a1f4","slug":"causes-contributing-factors","fullItemName":"Causes and contributing factors"},{"id":"4bbda54d-1a4f-591c-8463-082fcdf61d7c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e79a0901-9992-5f45-8cf5-c15ce06b5deb","slug":"complications","fullItemName":"Complications"},{"id":"b70db9b0-ddc3-5b42-888e-7171189f4ee5","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a84e9562-3c9c-5c5e-8832-06e65a89aa2f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"49f48003-2f49-51d5-acfe-7ba0fcff8fae","slug":"assessment-overview","fullItemName":"Assessment overview"},{"id":"060afa31-1619-5a1a-a7e5-bcb583129aca","slug":"assessing-the-type-of-urinary-incontinence","fullItemName":"Assessing the type of urinary incontinence"},{"id":"9897aa86-8c09-5550-8496-da8cb12787bf","slug":"assessing-for-underlying-causes-contributing-factors","fullItemName":"Assessing for underlying causes and contributing factors"},{"id":"49079af0-34b2-5cab-9135-40f57ee1eea4","slug":"assessing-for-complications","fullItemName":"Assessing for complications"},{"id":"c9c5f464-0433-5027-a22c-8d2b8fb239bd","slug":"assessing-the-severity-of-urinary-incontinence","fullItemName":"Assessing the severity of urinary incontinence"}]},{"id":"a7454b90-f574-597a-b3ce-8f0b3967e058","fullItemName":"Management","slug":"management","subChapters":[{"id":"26043de5-bad9-57d7-abad-98942e3ed62c","slug":"managing-stress-incontinence","fullItemName":"Scenario: Managing stress incontinence"},{"id":"280a972f-ec97-53b4-ab56-b67df1df40d3","slug":"managing-urgency-incontinence","fullItemName":"Scenario: Managing urgency incontinence"},{"id":"dff61990-c7a9-5600-b15a-e9098f480b65","slug":"managing-mixed-urinary-incontinence","fullItemName":"Scenario: Managing mixed urinary incontinence"},{"id":"4e21298e-b75d-5104-9b4b-a9817cb8d9b6","slug":"managing-overflow-urinary-incontinence","fullItemName":"Scenario: Managing overflow urinary incontinence"},{"id":"d5ace44e-cc5a-5618-bb48-24058af84ec8","slug":"managing-a-urogenital-fistula","fullItemName":"Scenario: Managing a urogenital fistula"}]},{"id":"d814319d-0309-591f-aa84-5dfa4933d33b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"3d2d4594-7f5e-5ad4-9537-22965cd3859f","slug":"antimuscarinics","fullItemName":"Antimuscarinics"},{"id":"c57e795e-2c4a-5f04-83ae-289890ef29ea","slug":"desmopressin","fullItemName":"Desmopressin"},{"id":"2bf52d86-2720-51b1-9411-89ebb7ff9b07","slug":"duloxetine","fullItemName":"Duloxetine"},{"id":"7f2a8cea-ac55-5ac4-a58a-52dbe5d19228","slug":"intravaginal-oestrogen","fullItemName":"Intravaginal oestrogen"},{"id":"2e7111be-d25f-52ec-9f6b-2aaea7583699","slug":"mirabegron","fullItemName":"Mirabegron"}]},{"id":"3ef95f2d-4da4-5002-9243-64779078fc11","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bdb709b8-1321-594d-b446-51244a4b8f41","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6ce87fd7-7343-5da1-b9a5-0035a5703c2c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3fe3b863-a1f0-5938-9f0d-bb718d670d28","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"947b96f3-7dc6-5136-96f6-431519b4646a","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"16662eed-08e1-5333-85c0-65d2e4722f09","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"9c5908f0-10fa-5d1c-8762-8a682a1ee2c8","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"532bc548-9f39-5742-9a38-cb92893a8407","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a84e9562-3c9c-5c5e-8832-06e65a89aa2f","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"ce6a0e95-1b7c-51ba-a61d-0f35133c4fd0","slug":"basis-for-recommendation-720","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 58f4c8f1-c319-4880-96f8-2b98a9173b33 --><h3>Basis for recommendation</h3><!-- end field 58f4c8f1-c319-4880-96f8-2b98a9173b33 -->","summary":null,"htmlStringContent":"<!-- begin item 72071827-8f20-475d-8572-70db52735a9b --><!-- begin field 9f467d82-25ba-462d-bc18-042994fbf812 --><h4>Causes and conditions that may exacerbate urinary incontinence</h4><ul><li>The recommendation to look for causes and conditions that may exacerbate urinary incontinence are based on the National Institute for Health and Care Excellence (NICE) guidelines <em>Urinary incontinence and pelvic organ prolapse in women: management</em>  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">NICE, 2019</a>] and <em>Urinary incontinence in women: the management of urinary incontinence in women </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">National Collaborating Centre for Women's and Children's Health, 2013</a>], and expert opinion from European guidelines on <em>Urinary incontinence  </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">EAU, 2018</a>]. </li><li>The potential causes to exclude are based on information in these sources, Australian and New Zealand guidelines on non-neurogenic overactive bladder [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Tse et al, 2016</a>], and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Barkin et al, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Itam and Singh, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Lukacz et al, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">BMJ Best Practice, 2018</a>]. <ul><li>Evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Tsakiris et al, 2008</a>]<strong> </strong>and there is little evidence to suggest that changing non-incontinence medication can improve urinary incontinence symptoms (and it may be harmful) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">EAU, 2018</a>]. </li><li>Previous surgery for urinary incontinence or pelvic organ prolapse may interfere with the normal support mechanisms of the vagina and urethra [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">National Collaborating Centre for Women's and Children's Health, 2013</a>].</li></ul></li></ul><h4>Exclude urinary tract infection</h4><ul><li>The recommendation to perform urinary dipstick analysis in all women presenting with urinary incontinence is based on the NICE guideline <em>Urinary incontinence and pelvic organ prolapse in women: management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">NICE, 2019</a>] and is consistent with European guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">EAU, 2018</a>]. <ul><li>Detection of haematuria, pyuria, and glycosuria can suggest a co-existing condition that is associated with incontinence and requires further assessment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Itam and Singh, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">Lukacz et al, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">EAU, 2018</a>]. </li><li>Urinary tract infection may cause incontinence or worsening of existing symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/incontinence-urinary-in-women/references/\">EAU, 2018</a>]. </li></ul></li></ul><!-- end field 9f467d82-25ba-462d-bc18-042994fbf812 --><!-- end item 72071827-8f20-475d-8572-70db52735a9b -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}